Annexon (ANNX) to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]
Annexon, Inc. - common stock (ANNX)
Company Research
Source: Yahoo! Finance
Annexon is expected to report first-quarter 2024 results soon. Having no commercialized product in its portfolio or any ongoing collaboration agreements, the company currently does not generate any revenues. The Zacks Consensus Estimate is pegged at a loss of 32 cents per share, indicating an increase of 38.5% year over year. Let's see how things might have shaped up for the quarter to be reported. Factors to Consider In the absence of a marketed product, investors will mostly focus on progress updates regarding the company's pipeline candidates. Annexon has channeled its resources to prioritize three flagship development programs in its clinical-stage pipeline, such as ANX005 for Guillain-Barré syndrome (GBS), ANX007 for geographic atrophy (GA) and first-in-kind oral complement small molecule, and ANX1502 for several autoimmune indications. In the fourth quarter of 2024, the company reported that it had completed enrollment in the phase III study evaluating the efficacy, s
Show less
Read more
Impact Snapshot
Event Time:
ANNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANNX alerts
High impacting Annexon, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
ANNX
News
- Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Annexon, Inc. (NASDAQ: ANNX) had its price target lowered by analysts at Wells Fargo & Company from $12.00 to $10.00. They now have an "overweight" rating on the stock.MarketBeat
- Annexon, Inc. (NASDAQ: ANNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.MarketBeat
- We Think Annexon (NASDAQ:ANNX) Can Afford To Drive Business Growth [Yahoo! Finance]Yahoo! Finance
- Annexon, Inc. (NASDAQ: ANNX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $16.00 price target on the stock.MarketBeat
ANNX
Earnings
- 5/13/24 - Beat
ANNX
Sec Filings
- 5/13/24 - Form 10-Q
- 5/13/24 - Form 8-K
- 5/7/24 - Form 8-K
- ANNX's page on the SEC website